Navigation Links
Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness"
Date:1/14/2014

updates from the event. For more Kinaxis news, follow us on LinkedIn, Twitter or Facebook.

About Kinaxis
Kinaxis delivers a cloud-based SCM and S&OP service. Large manufacturing companies with complex supply chain networks and volatile business environments rely on RapidResponse for collaborative planning, continuous performance monitoring, and coordinated response to plan variances across multiple areas of the business. With RapidResponse, enterprises are able to attain a control tower solution that encompasses a full spectrum of supply chain related business processes, including such functions as: S&OP, supply and capacity planning, demand planning, and supplier collaboration. As a result, Kinaxis customers have replaced disparate planning and performance management tools and are realizing significant operations performance breakthroughs. From a single product, customers are able to make both long-term and real-time demand and supply balancing decisions quickly, collaboratively, and in line with the shared business objectives of multiple stakeholders.

Contact:
Melissa Clow
mclow@kinaxis.com


'/>"/>
SOURCE Kinaxis
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Bayer CropScience’s Bee Care Program Promotes Honey Bee Health Awareness Through Key Industry Events
2. Verified Clinical Trials Stops Dual Enrollment in Clinical Trials in Major CNS Clinical Trials to Reduce Potential Adverse Events and Improve Data Quality
3. SoundConnect Expands Distribution of Adobe Connect Event Module
4. Verified Clinical Trials Selected to Prevent Dual Enrollment in Clinical Trials, Will Add Over 800 Additional Sites for a New Phase 3 North American Clinical Trial
5. The Conferences Forum Launches Patients as Partners Event
6. To Prevent or Ease Arthritis, Put Down the Sugar and Pick Up Stevia
7. InspireMD Announces Upcoming Investor Event in Israel
8. Product Development Technologies Team Attending Back End of Innovation Event
9. Safety Recommendations Address Blood Clot Prevention for Pregnant Mothers: Physician-Patient Alliance for Health & Safety Presentation at National Perinatal Association Conference
10. Synthetic Biologics SYN-004 for the Prevention of C. difficile Infections Named a "Top Project to Watch" by Elsevier Business Intelligence
11. CONRAD presents new technology combining contraception, HIV and herpes simplex virus-2 prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... today announced that it will be presenting at CALBIO ... 2 nd at 3pm PST. Patrick Lucy, chief business ... the current state of the biosimilar industry landscape entitled ... For more information on CALBIO 2015 and ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015   Regulus ... biopharmaceutical company leading the discovery and development of innovative ... Xanthopoulos , Ph.D., President and Chief Executive Officer of ... and Company 35 th Annual Healthcare Conference on ... conference is being held at the Boston Marriott Copley ...
(Date:2/26/2015)... , Feb. 26, 2015  NuGene International, Inc. ... products for skin and hair rejuvenation, has announced ... agency of record for investor relations and strategic ... our distribution, sales and diversification strategies – and ... and prospective shareholders," stated Ali Kharazmi CEO of ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3
... LEXINGTON, Mass., Aug. 28 Instrumentation Laboratory,(IL) today ... (FDA) has,granted 510(k) clearance to expand the intended ... thromboembolism (VTE) in outpatients suspected of,deep venous thrombosis ... with a clinical pretest probability (PTP) assessment model.,HemosIL ...
... Agency (ESA) has appointed the UK,s National Physical Laboratory ... group will lead a consortium to identify the next ... used in future space missions. , "Advances in nanotechnology ... Higher Research Scientist in the nanomaterials group at NPL, ...
... LAKES, N.J., Aug. 27 BD (Becton,Dickinson and Company) ... today that it would present at the following investor ... September 4, 2008 1:30 p.m. EDT, Morgan ... 8:00 a.m. EDT, A live webcast of ...
Cached Biology Technology:Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay 2
(Date:2/23/2015)... Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... patent 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT ... introduces a new groundbreaking payment method. Payment accounts may ... may only be accessed if both the speech (the ...
(Date:2/13/2015)... -- ACT Genomics Co., Ltd., a cancer molecular ... genomic information into precision diagnosis and personalized treatments, ... million in the its first private funding round. ... , ACT Genomics has developed comprehensive cancer ... implement next generation sequencing (NGS) and multiplex molecular ...
(Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... Children with Duchenne muscular dystrophy (DMD) face a future ... respiratory or cardiac failure before their 30th birthday. While researchers ... effective treatment, few have targeted the heart of the problem ... new $2.1 million grant he received from the National Institutes ...
... Studies on genetically engineered mice show that social stress ... atherosclerosis. Commonly used drugs to reduce blood pressure, however, ... a thesis presented at the University of Gothenburg, Sweden. ... is a correlation between psychosocial stress and the risk ...
... Sledge Jr., M.D., a nationally recognized pioneer in the ... the 2010 William L. McGuire Memorial Lecture Award at ... Supported by GlaxoSmithKline Oncology (GSK) since its inception ... for their significant contributions to breast cancer research. ...
Cached Biology News:New NIH grant helps MU scientist get to the heart of muscular dystrophy 2Social stress leads to atherosclerosis 2George W. Sledge, Jr., M.D., honored for international contributions to breast cancer research 2
...
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
Form: Concentrated Applications: ELISA...
RABBIT ANTI HALOPERIDOL...
Biology Products: